skinny.

Latest / Stock Movers

Synaptics Rises, Lumentum Falls, Acadia Pharma Jumps on Positive CHMP Drug Opinion

On this episode of Stock Movers:

Synaptics (SYNA) shares rise. Onsemi has agreed to buy Synaptics Inc. in an all-stock deal that values the company at about $6.2 billion. The transaction has a total enterprise value including debt of roughly $7 billion and is expected to close in mid-2027, subject to approvals.

Lumentum (LITE) shares fall. U.S. optical communication stocks dropped. This comes as Semiconductor stocks are broadly lower.

Acadia Pharma (ACAD) shares climb as much as 12%, the most intraday since May 2025, after the drugmaker said the European Medicines Agency’s CHMP issued a…

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.